{
    "2018-12-12": [
        [
            {
                "time": "2019-01-01",
                "original_text": "Pharma Stocks That Could Cure Ailing Portfolios in 2019",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Cure",
                        "Ailing Portfolios",
                        "2019"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "3 Stocks That Could Help You Send Your Kids to College",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Help",
                        "Kids",
                        "College"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "education"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "Pfizer's Shares Drop on Rating Downgrade by JP Morgan",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Shares Drop",
                        "Rating Downgrade",
                        "JP Morgan"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "Health Care Sector Update for 12/12/2018: SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "SGYP",
                        "NBIX",
                        "MRNS",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-12",
                "original_text": "5 Bargain Dividend Stocks to Buy Now",
                "features": {
                    "keywords": [
                        "Bargain",
                        "Dividend",
                        "Stocks",
                        "Buy Now"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividends"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Report: Developing Opportunities within Pfizer, Bed Bath & Beyond, Vishay Intertechnology, Cloudera, Markel, and QTS Realty Trust â€” Future Expectations, Projections Moving into 2018",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Bed Bath & Beyond",
                        "Vishay Intertechnology",
                        "Cloudera",
                        "Markel",
                        "QTS Realty Trust",
                        "Future Expectations",
                        "Projections",
                        "2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "retail",
                        "technology",
                        "real estate"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}